Tau binding protein CAPON induces tau aggregation and neurodegeneration
To understand the molecular processes that link Aβ amyloidosis, tauopathy and neurodegeneration, the authors screened for tau-interacting proteins. They demonstrated that a novel tau binding protein CAPON accelerates tau pathology and neuronal cell death in an Alzheimer’s disease mouse model.
Guardado en:
Autores principales: | Shoko Hashimoto, Yukio Matsuba, Naoko Kamano, Naomi Mihira, Naruhiko Sahara, Jiro Takano, Shin-ichi Muramatsu, Takaomi C. Saido, Takashi Saito |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6d5539c0c38d49df96dcc5ad495fe5b8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Author Correction: Tau binding protein CAPON induces tau aggregation and neurodegeneration
por: Shoko Hashimoto, et al.
Publicado: (2019) -
EGCG impedes human Tau aggregation and interacts with Tau
por: Shweta Kishor Sonawane, et al.
Publicado: (2020) -
Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration
por: Marlies Gijs, et al.
Publicado: (2021) -
Tau K321/K353 pseudoacetylation within KXGS motifs regulates tau–microtubule interactions and inhibits aggregation
por: Yuxing Xia, et al.
Publicado: (2021) -
An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline
por: Hanna Trzeciakiewicz, et al.
Publicado: (2020)